Silence Therapeutics (SLN) Net Margin: 2020-2025
Historic Net Margin for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to -13,181.13%.
- Silence Therapeutics' Net Margin fell 1080837.00% to -13,181.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -249.86%, marking a year-over-year increase of 11993.00%. This contributed to the annual value of -104.74% for FY2024, which is 6663.00% up from last year.
- Silence Therapeutics' Net Margin amounted to -13,181.13% in Q3 2025, which was down 7.94% from -12,211.61% recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Net Margin peaked at 48.61% during Q4 2024, and registered a low of -20,091.55% during Q1 2025.
- Its 3-year average for Net Margin is -4,697.90%, with a median of -713.01% in 2023.
- Per our database at Business Quant, Silence Therapeutics' Net Margin soared by 76,162bps in 2024 and then tumbled by 2,007,682bps in 2025.
- Quarterly analysis of 5 years shows Silence Therapeutics' Net Margin stood at -328.85% in 2021, then surged by 1,301bps to -315.84% in 2022, then tumbled by 39,716bps to -713.01% in 2023, then soared by 76,162bps to 48.61% in 2024, then crashed by 1,080,837bps to -13,181.13% in 2025.
- Its last three reported values are -13,181.13% in Q3 2025, -12,211.61% for Q2 2025, and -20,091.55% during Q1 2025.